Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout

Development of a Pseudotyped-Lentiviral-Vector-Based Neutralization Assay for Chikungunya Virus Infection

(2013) N. Kishishita et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein

(2012) Yiu-Wing Kam et al.   EMBO Molecular Medicine

Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical Protection

(2012) Yiu-Wing Kam et al.   JOURNAL OF INFECTIOUS DISEASES

Epidemiology of chikungunya infection on Reunion Island, Mayotte, and neighboring countries

(2012) P. Renault et al.   MEDECINE ET MALADIES INFECTIEUSES

Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus

(2012) Manish Kumar et al.   VACCINE

Detection of Chikungunya Virus in Wild Populations of Aedes albopictus in Kerala State, India

(2012) Narendran Pradeep Kumar et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice

(2012) Mohsin Khan et al.   VIRUS RESEARCH

Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays

(2011) Leena Pohjala et al.   PLoS One

A Chikungunya Outbreak Associated with the Vector Aedes albopictus in Remote Villages of Gabon

(2011) Christophe Paupy et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo

(2009) Bakhos A Tannous   Nature Protocols

A secreted luciferase for ex vivo monitoring of in vivo processes

(2008) Thomas Wurdinger et al.   NATURE METHODS

Chimeric alphavirus vaccine candidates for chikungunya

(2008) Eryu Wang et al.   VACCINE